Published in
Springer, Annals of Hematology, 4(100), p. 1023-1029, 2020
DOI: 10.1007/s00277-020-04056-9
Links
Tools
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Journal article published in 2020 by
Eva González Barca,
Francisco Javier Capote,
Capote Fj,
Juan-Manuel Sancho,
Jose Gómez Codina,
Carlos Panizo 
,
Antonio Salar,
Sancho Jm,
Andres López,
Javier Briones,
Alberto Fernández de Sevilla,
Andres Muñoz,
Maite Encuentra,
Santiago Mercadal,
Eva Domingo Domenech
and other authors.
,
Antonio Salar,
Sancho Jm,
Andres López,
Javier Briones,
Alberto Fernández de Sevilla,
Andres Muñoz,
Maite Encuentra,
Santiago Mercadal,
Eva Domingo Domenech
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 